These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23016641)

  • 1. Brain delivery systems via mechanism independent of receptor-mediated endocytosis and adsorptive-mediated endocytosis.
    Thomsen LB; Lichota J; Eskehave TN; Linemann T; Mortensen JH; du Jardin KG; Moos T
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2349-54. PubMed ID: 23016641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticle-derived non-viral genetic transfection at the blood-brain barrier to enable neuronal growth factor delivery by secretion from brain endothelium.
    Thomsen LB; Larsen AB; Lichota J; Moos T
    Curr Med Chem; 2011; 18(22):3330-4. PubMed ID: 21728969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adsorptive-mediated brain delivery systems.
    Lu W
    Curr Pharm Biotechnol; 2012 Sep; 13(12):2340-8. PubMed ID: 23016640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood-brain barrier endogenous transporters as therapeutic targets: a new model for small molecule CNS drug discovery.
    Pardridge WM
    Expert Opin Ther Targets; 2015; 19(8):1059-72. PubMed ID: 25936389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CNS delivery via adsorptive transcytosis.
    Hervé F; Ghinea N; Scherrmann JM
    AAPS J; 2008 Sep; 10(3):455-72. PubMed ID: 18726697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano carriers for drug transport across the blood-brain barrier.
    Li X; Tsibouklis J; Weng T; Zhang B; Yin G; Feng G; Cui Y; Savina IN; Mikhalovska LI; Sandeman SR; Howel CA; Mikhalovsky SV
    J Drug Target; 2017 Jan; 25(1):17-28. PubMed ID: 27126681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Routes for Drug Translocation Across the Blood-Brain Barrier: Exploiting Peptides as Delivery Vectors.
    Kristensen M; Brodin B
    J Pharm Sci; 2017 Sep; 106(9):2326-2334. PubMed ID: 28501469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular drug transport into the brain using targeted therapy.
    Lichota J; Skjørringe T; Thomsen LB; Moos T
    J Neurochem; 2010 Apr; 113(1):1-13. PubMed ID: 20015155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of drugs across the blood-brain barrier by nanoparticles.
    Wohlfart S; Gelperina S; Kreuter J
    J Control Release; 2012 Jul; 161(2):264-73. PubMed ID: 21872624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crossing the Blood-Brain Barrier: Recent Advances in Drug Delivery to the Brain.
    Patel MM; Patel BM
    CNS Drugs; 2017 Feb; 31(2):109-133. PubMed ID: 28101766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted drug delivery across the blood brain barrier in Alzheimer's disease.
    Rocha S
    Curr Pharm Des; 2013; 19(37):6635-46. PubMed ID: 23621533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier.
    Sharma G; Sharma AR; Lee SS; Bhattacharya M; Nam JS; Chakraborty C
    Int J Pharm; 2019 Mar; 559():360-372. PubMed ID: 30721725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosis at the blood-brain barrier: from basic understanding to drug delivery strategies.
    Smith MW; Gumbleton M
    J Drug Target; 2006 May; 14(4):191-214. PubMed ID: 16777679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinatorial approaches for the identification of brain drug delivery targets.
    Stutz CC; Zhang X; Shusta EV
    Curr Pharm Des; 2014; 20(10):1564-76. PubMed ID: 23789958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accessing targeted nanoparticles to the brain: the vascular route.
    Burkhart A; Azizi M; Thomsen MS; Thomsen LB; Moos T
    Curr Med Chem; 2014; 21(36):4092-9. PubMed ID: 25039779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crossing the blood-brain barrier with nanoparticles.
    Zhou Y; Peng Z; Seven ES; Leblanc RM
    J Control Release; 2018 Jan; 270():290-303. PubMed ID: 29269142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to overcome the barrier: use of nanoparticles as carriers and modulators of barrier properties.
    Rempe R; Cramer S; Qiao R; Galla HJ
    Cell Tissue Res; 2014 Mar; 355(3):717-26. PubMed ID: 24585360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor-mediated therapeutic transport across the blood-brain barrier.
    Wang YY; Lui PC; Li JY
    Immunotherapy; 2009 Nov; 1(6):983-93. PubMed ID: 20635914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles as novel carrier for brain delivery: a review.
    Agarwal A; Lariya N; Saraogi G; Dubey N; Agrawal H; Agrawal GP
    Curr Pharm Des; 2009; 15(8):917-25. PubMed ID: 19275654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harnessing the capacity of cell-penetrating peptides for drug delivery to the central nervous system.
    Kang T; Gao X; Chen J
    Curr Pharm Biotechnol; 2014; 15(3):220-30. PubMed ID: 24938893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.